A GLP-1 receptor agonist commonly used to treat type 2 diabetes could help reduce the development of motor skills deterioration in people with early-stage Parkinson’s, a new study indicates.
While our personalities remain stable across our lives, they also remain at least somewhat malleable, says a new review that describes how to successfully make changes to who we are.